Cas:4783-82-8 2-(4-bromophenoxy)pyridine manufacturer & supplier

We serve Chemical Name:2-(4-bromophenoxy)pyridine CAS:4783-82-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-(4-bromophenoxy)pyridine

Chemical Name:2-(4-bromophenoxy)pyridine
CAS.NO:4783-82-8
Synonyms:2-(p-Bromphenyloxy)-pyridin;2-(2-CHLOROPHENYL)-6,8-DIMETHYLQUINOLINE-4-CARBOXYLIC ACID;2-<4-Brom-phenoxy>-pyridin;4-bromo-1-(2-pyridyloxy)benzene;2-(4-bromophenoxy)-pyridine;Pyridine,2-(4-bromophenoxy)
Molecular Formula:C11H8BrNO
Molecular Weight:250.09100
HS Code:2933399090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:322.4ºC at 760mmHg
Density:1.476g/cm3
Index of Refraction:
PSA:22.12000
Exact Mass:248.97900
LogP:3.63640

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-(p-Bromphenyloxy)-pyridin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Pyridine,2-(4-bromophenoxy) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-&lt Use and application,2-(p-Bromphenyloxy)-pyridin technical grade,usp/ep/jp grade.


Related News: Today the international business represents 25 percent of BetterUp’s members, who access the platform through global enterprise partners including Allianz, Hilton, Snap Inc. and Mars. (4-(diisopropylcarbamoyl)-2-isopropoxybenzoyl)-L-leucine manufacturers Mindset is developing several novel families of next generation psychedelic compounds, as well as an innovative process to chemically synthesize psilocybin as well as its own proprietary compounds. N-[4-(3-cyclobutylaminomethyl-4-hydroxy-phenoxy)-3,5-dimethyl-phenyl]-oxamic acid ethyl ester suppliers “The Agency also noted that no effect was seen in the two studies that included patients from EU populations, including the most recent study which involved patients who were receiving the maximum and optimal treatment for their Parkinson’s disease,” EMA said. 2′-hydroperoxy-2’H-13,1’3,1’4,1”3,24,2’4,2’3,2”4,33,3’3,3’3,3”4,43,4’3,4’4,4”3,53,5’4,5”3,63,6’3,6’3,6”3-[2,2′:5′,1′:4′,2”-quaterhexaoxin]-3”-ol vendor & factory.